| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |